Insider · CIK 0001730700
Chris Whitehair
Files at SNAX (STRYVE FOODS, INC.). First filing -, latest -.
In brief
Chris Whitehair files SEC Form 4 as director at SNAX (STRYVE FOODS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Chris Whitehair has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | SNAX STRYVE FOODS, INC. | AGrant or award Class A Common Stock | +5,500 | $0.00 | $0 | 15,088 | Jun 16, 2025 |
| Dec 31, 2023 | SNAX STRYVE FOODS, INC. | AGrant or award Class A Common Stock | +2,038 | $0.00 | $0 | 4,088 | Jan 5, 2024 |
| Sep 30, 2023 | SNAX STRYVE FOODS, INC. | AGrant or award Class A Common Stock | +724 | $0.00 | $0 | 2,050 | Nov 14, 2023 |
| Sep 30, 2023 | SNAX STRYVE FOODS, INC. | AGrant or award Class A Common Stock | +724 | $0.00 | $0 | 20,613 | Nov 13, 2023 |
Questions about Chris Whitehair
Answered from the filings on this page, as of the latest one.
Is Chris Whitehair buying or selling?
Chris Whitehair has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Chris Whitehair's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chris Whitehair has 0.
Where does Chris Whitehair file Form 4?
Chris Whitehair has filed Form 4 at SNAX (STRYVE FOODS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.